Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
US OptionsDetailed Quotes
ONC250516C320000
- 1.10
- 0.000.00%
15min DelayClose Apr 30 16:00 ET
0.00High0.00Low
1.10Open1.10Pre Close0 Volume7 Open Interest320.00Strike Price0.00Turnover65.51%IV23.59%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry1.10Extrinsic Value100Contract SizeAmericanOptions Type0.0735Delta0.0039Gamma236.19Leverage Ratio-0.1549Theta0.0078Rho17.36Eff Leverage0.0752Vega
BeiGene Newsroom
BEIGENE (06160.HK) will release its Earnings Reports on May 7.
$BEIGENE (06160.HK)$ will release its Earnings Reports on May 7th, investors please pay attention. How was the performance previously? $BEIGENE (06160.HK)$ 2024 Q4 revenue was $1.128 billion, Net income was -$-0.152 billion, and EPS was -$0.11. 2024 Q1 revenue was $0.752 billion, Net income was -$-0.251 billion, and EPS was -$0.19. Futubull reminds: 1. There are no strict regulations on the accounting year divisions for companies listed on Hong Kong and US stock exchanges, and it is entirely up to the companies to decide. Therefore, each Earnings Reports period can be considered as a business.
Top Gap Ups and Downs on Wednesday: SAN, SBUX, MDLZ and More
US stock movement | BEIGENE (ONC.US) rose over 3% as revenue for 2024 increased by 55% year-on-year.
On Wednesday, BEIGENE (ONC.US) rose over 3%, reaching $259.
BEIGENE (06160) rises by 6.11% after winning the patent dispute in the USA.
Jingwu Financial News | BEIGENE (06160) is fluctuating strongly, as of this report, up 6.11%, at HKD 158.1, with a transaction amount of 0.618 billion HKD. In terms of news, BEIGENE announced that the US Patent and Trademark Office made a final written decision, declaring that Pharmacyclics LLC's rights to US Patent No. 11,672,803, which was challenged by BEIGENE during the post-grant review process, are completely invalid. On November 1, 2023, regarding the patent infringement suit filed by Pharmacyclics against BEIGENE concerning BRUKINSA.
Express News | Beigene Says Pharmacyclics Litigation Is Not Expected to Have Adverse Effect on Co's Production, Operation
Express News | Beigene Says Pharmacyclics Litigation Is Not Having Adverse Effect on Development, Sales of Brukinsa in U.S.
BEIGENE (06160.HK) issued 0.2147 million shares due to the vesting of restricted share units.
Gelonghui reported on April 30 that BEIGENE (06160.HK) announced that on April 29, 2025, it will issue 0.2147 million ordinary shares due to the vesting of restricted stock units granted under the equity plan (excluding company Directors).
BEIGENE (06160) won the patent dispute in the USA as the USPTO ruled that the Pharmacyclics patent is invalid.
BEIGENE (06160) announced that the USPTO made a final written decision regarding Phar...
BEIGENE's revenue growth in 2024, narrowing losses, and core products gaining global traction.
① The company achieved a revenue of 27.214 billion yuan for the year, with a year-on-year increase of 56.19%; the net income attributable to shareholders was -4.978 billion yuan, a decrease of 17.38% from the previous year; the net income excluding non-recurring items was -5.379 billion yuan, a year-on-year decrease of 17.38%; ② The revenue share of Baiyueze and Baizean continues to expand, driving the company's revenue growth.
BeiGene Ltd. Successfully Passes Key Resolutions at EGM
BEIGENE (688235.SH) released its performance for the year 2024, with revenue of 27.214 billion yuan, a year-on-year increase of 56.19%.
BEIGENE (688235.SH) released its annual report for 2024, with the revenue for the year 2024 being 27...
BeiGene Shenzhou Co., Ltd. 2024 Annual Report
BeiGene Shenzhou Co., Ltd. 2024 Annual Report Summary
Express News | RBC Capital Reiterates Outperform on BeiGene, Maintains $312 Price Target
BeiGene Analyst Ratings
US Stock Movement | BEIGENE (ONC.US) rises over 2% Institutions: Innovative Drugs from mainland China are not affected by tariffs when going overseas.
On Monday, BEIGENE (ONC.US) rose over 2%, closing at $251.10.
Express News | Beigene 2024 Net Loss at 5.0 Bln Yuan
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), BeiGene (ONC) and BioNTech SE (BNTX)
BEIGENE: 2024 ANNUAL REPORT
Express News | JPMorgan Chase & Co's Long Position in Shares of Beigene Increases to 9.07% on April 22 From 8.57% - HKEX
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now